Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3944]

A conversational artificial intelligence system enhances precision medicine and...

Dr Enrique Velazquez Villarreal - City of Hope, Duarte, USA

A conversational artificial intelligence system enhances precision medicine and health equity ( Dr Enrique Velazquez Villarreal - City of Hope, Duarte, USA )

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics...

Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration ( Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA )

Metastasis-directed radiotherapy shows good prognosis for oligometastatic...

Dr Chad Tang - MD Anderson Cancer Center, Houston, USA

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer ( Dr Chad Tang - MD Anderson Cancer Center, Houston, USA )

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair...

Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York...

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours ( Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal...

Dr Aditya Shreenivas - CIty of Hope, Duarte, USA

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal cancer shows positive results ( Dr Aditya Shreenivas - CIty of Hope, Duarte, USA )

Addition of pembrolizumab to standard care shows promising results in advanced...

Dr Ravindra Uppaluri - Dana-Farber Brigham Cancer Center, Boston, USA

Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer ( Dr Ravindra Uppaluri - Dana-Farber Brigham Cancer Center, Boston, USA )

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna...

ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in...

Dr Giulia Pasello - University of Padova, Padua, Italy

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC ( Dr Giulia Pasello - University of Padova, Padua, Italy )

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA...

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )

Perioperative durvalumab in addition to neoadjuvant chemotherapy shows positive...

Dr Sacha Rothschild - University of Basel, Basel, Switzerland

Perioperative durvalumab in addition to neoadjuvant chemotherapy shows positive results in patients with stage IIIa(N2) NSCLC ( Dr Sacha Rothschild - University of Basel, Basel, Switzerland )

Pembrolizumab plus cCRT continue to demonstrate antitumour activity in advanced...

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany

Pembrolizumab plus cCRT continue to demonstrate antitumour activity in advanced NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )

Treatment with BAY 2927088 led to durable responses in patients previously...

Prof Nicolas Girard - Institut Curie, Paris, France

Treatment with BAY 2927088 led to durable responses in patients previously treated HER2-mutant NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

More from ecancer